Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
203M
-
Shares change
-
-1.68M
-
Total reported value, excl. options
-
$185M
-
Value change
-
+$159K
-
Put/Call ratio
-
1.61
-
Number of buys
-
52
-
Number of sells
-
-37
-
Price
-
$0.91
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q4 2023
121 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q4 2023.
Gossamer Bio, Inc. - Common Stock (GOSS) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 203M shares
of 227M outstanding shares and own 89.43% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (15.8M shares), FMR LLC (12.3M shares), Artal Group S.A. (12.1M shares), VANGUARD GROUP INC (11.6M shares), EcoR1 Capital, LLC (9.2M shares), Octagon Capital Advisors LP (9.19M shares), ARCH Venture Management, LLC (8.06M shares), PLATINUM INVESTMENT MANAGEMENT LTD (6.95M shares), Eversept Partners, LP (6.43M shares), and CITADEL ADVISORS LLC (6.14M shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.